There is an urgent need to improve mental health outcomes among young people. One approach taken to address this problem has been the design and delivery of universal school-based prevention, based o…
This Medical News article is an interview with Dana P. Edelson, MD, MS, an expert in cardiac resuscitation at the University of Chicago and cofounder…
A diagnosis of prostate cancer (PC) is a life-changing event that often prompts asymptomatic men to opt for local treatment. The cancer control afforded by…
/PRNewswire/ — GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating…
The ISTH 2025 Congress is the premier international medical and scientific conference for experts in the fields of thrombosis, hemostasis and vascular biology. Join us…
Abstract. Multiple chimeric antigen receptor (CAR) T-cell therapies are US Food and Drug Administration–approved, and several are under development. Althou
BMT CTN 0901 enrolled patients with MDS (N=54) or AML (N=218) (median age of 55 years) who had < 5% marrow blasts by morphology prior…
Disclosures. Abedin:AbbVie, Daichii Sankyo, Servier: Consultancy, Honoraria; Actinium Pharmaceutical, AltruBio, Incyte: Research Funding. Al Malki:Tr1X: Co
Program: Late-breaking Abstracts Session: Late-Breaking Abstracts Session Hematology Disease Topics & Pathways: Research, Clinical trials, Lymphomas, Non-Hodgkin lymphoma, Clinical Research, B Cell lymphoma, Diseases, Lymphoid…
Blood Cancer Journal – Updated analysis of EMN02 demonstrated overall survival benefit to early ASCT for multiple myeloma
